Acetylated H4K16 by MYST1 protects UROtsa cells from arsenic toxicity and is decreased following chronic arsenic exposure.

Department of Nutritional Sciences and Toxicology, University of California Berkeley, Berkeley, CA 94720, USA.
Toxicology and Applied Pharmacology (Impact Factor: 3.63). 10/2009; 241(3):294-302. DOI: 10.1016/j.taap.2009.08.027
Source: PubMed

ABSTRACT Arsenic, a human carcinogen that is associated with an increased risk of bladder cancer, is commonly found in drinking water. An important mechanism by which arsenic is thought to be carcinogenic is through the induction of epigenetic changes that lead to aberrant gene expression. Previously, we reported that the SAS2 gene is required for optimal growth of yeast in the presence of arsenite (As(III)). Yeast Sas2p is orthologous to human MYST1, a histone 4 lysine 16 (H4K16) acetyltransferase. Here, we show that H4K16 acetylation is necessary for the resistance of yeast to As(III) through the modulation of chromatin state. We further explored the role of MYST1 and H4K16 acetylation in arsenic toxicity and carcinogenesis in human bladder epithelial cells. The expression of MYST1 was knocked down in UROtsa cells, a model of bladder epithelium that has been used to study arsenic-induced carcinogenesis. Silencing of MYST1 reduced acetylation of H4K16 and induced sensitivity to As(III) and to its more toxic metabolite monomethylarsonous acid (MMA(III)) at doses relevant to high environmental human exposures. In addition, both As(III) and MMA(III) treatments decreased global H4K16 acetylation levels in a dose- and time-dependent manner. This indicates that acetylated H4K16 is required for resistance to arsenic and that a reduction in its levels as a consequence of arsenic exposure may contribute to toxicity in UROtsa cells. Based on these findings, we propose a novel role for the MYST1 gene in human sensitivity to arsenic.

Download full-text


Available from: Henri Wintz, Jul 02, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aberrant histone acetylation has been observed in carcinogenesis and cellular transformation associated with arsenic exposure, however the molecular mechanisms and cellular outcomes of such changes are poorly understood. We investigated the impact of tolerated and toxic As2O3 exposure in human embryonic kidney (HEK293T) and urothelial (UROtsa) cells to characterise the alterations in histone acetylation, gene expression and the implications for cellular transformation. Tolerated and toxic exposures of As2O3 were identified by measurement of cell death, mitochondrial function, cellular proliferation and anchorage-independent growth. Histone extraction, MNase sensitivity assay and immunoblotting were used to assess global histone acetylation levels and gene promoter specific interactions were measured by chromatin immunoprecipitation followed by reverse-transcriptase polymerase chain reaction. Tolerated and toxic dosages were defined as 0.5 µM and 2.5 µM As2O3 in HEK293T cells and 1 µM and 5 µM As2O3 in UROtsa cells respectively. Global hypo-acetylation of H3K9 at 72 hours was observed in UROtsa cells following tolerated and toxic exposure. In both cell lines, tolerated exposure alone led to H3K9 hyper-acetylation and E2F1 binding at the FOS promoter, which remained elevated after 72 hours contrary to global H3K9 hypo-acetylation. Thus, promoter specific H3K9 acetylation is a better predictor of cellular transformation than global histone acetylation patterns. Tolerated exposure resulted in an increased expression of proto-oncogenes FOS and JUN in both cell lines at 72 hours. Global H3K9 hypo-acetylation and promoter-specific hyper-acetylation facilitate E2F1-mediated FOS induction in As2O3-induced cellular transformation.
    Environmental Health Perspectives 01/2015; DOI:10.1289/ehp.1408302 · 7.03 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Exposure to organochlorinated pesticides such as dieldrin has been linked to Parkinson's and Alzheimer's disease, endocrine disruption, and cancer, but the cellular and molecular mechanisms of toxicity behind these effects remain largely unknown. Here we demonstrate, using a functional genomics approach in the model eukaryote Saccharomyces cerevisiae, that dieldrin alters leucine availability. This model is supported by multiple lines of congruent evidence: (1) mutants defective in amino acid signaling or transport are sensitive to dieldrin, which is reversed by the addition of exogenous leucine; (2) dieldrin sensitivity of wild-type or mutant strains is dependent upon leucine concentration in the media; (3) overexpression of proteins that increase intracellular leucine confer resistance to dieldrin; (4) leucine uptake is inhibited in the presence of dieldrin; and (5) dieldrin induces the amino acid starvation response. Additionally, we demonstrate that appropriate negative regulation of the Ras/PKA pathway, along with an intact pyruvate dehydrogenase complex, is required for dieldrin tolerance. Many yeast genes described in this study have human orthologs that may modulate dieldrin toxicity in humans.
    Toxicological Sciences 01/2013; 132(2). DOI:10.1093/toxsci/kft018 · 4.48 Impact Factor